The European Commission has concluded with BioNTech-Pfizer an amendment to the agreement for the purchase of vaccines to allow Member States a more flexible delivery allowing doses to be stored in centralized stocks.
At the request of a Member State, the delivery of vaccines will be made to a designated central storage facility, instead of being delivered directly to the Member State. The aim is, on the one hand, to help Member States to better manage the storage of the requested doses and, on the other hand, to provide them with additional storage capacity.
The agreement has been negotiated by the European Executive at the request of the Member States, following the strategy of joint purchases that allowed equal access to coronavirus vaccines in Europe during the coronavirus pandemic.
With this amendment, the EU countries will be in a position to better plan and manage their vaccine supplies to protect their citizens against the pandemic and to be ready to face possible increases in the number of cases, said the European Commissioner for Health, Stella Kyriakides.
«Solutions such as these demonstrate the European Health Union: being prepared to protect the public health of our citizens,» the Cypriot Commissioner welcomed.
